Disclosed is an ORL-1 receptor agonist having more excellent metabolic stability and stronger and higher selectivity than conventional compounds. The ORL-1 receptor agonist is therefore improved in bioavailability. Specifically disclosed is a compound represented by the following general formula (I). (In the formula, the symbols are as defined in the description.)